Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
14.13
-0.03 (-0.21%)
At close: Aug 1, 2025, 4:00 PM
14.41
+0.28 (1.98%)
After-hours: Aug 1, 2025, 6:20 PM EDT
Eton Pharmaceuticals Market Cap
Eton Pharmaceuticals has a market cap or net worth of $378.93 million as of August 1, 2025. Its market cap has increased by 310.86% in one year.
Market Cap
378.93M
Enterprise Value
391.67M
1-Year Change
310.86%
Ranking
Category
Stock Price
$14.13
Market Cap Chart
Since November 13, 2018, Eton Pharmaceuticals's market cap has increased from $105.74M to $378.93M, an increase of 258.36%. That is a compound annual growth rate of 20.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 378.93M | 6.81% |
| Dec 31, 2024 | 354.78M | 215.68% |
| Dec 29, 2023 | 112.38M | 57.54% |
| Dec 30, 2022 | 71.34M | -32.42% |
| Dec 31, 2021 | 105.56M | -46.38% |
| Dec 31, 2020 | 196.86M | 53.54% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 13, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.35B |
| Johnson & Johnson | 402.82B |
| AbbVie | 334.40B |
| UnitedHealth Group | 241.34B |
| AstraZeneca | 236.88B |
| Novartis AG | 227.02B |
| Abbott Laboratories | 223.66B |
| Novo Nordisk | 221.96B |